Enochian Biosciences Inc. announced William A. Haselstine PhD as a newly appointed member of the company’s Board of Directors. Dr. Haseltine is known for his pioneering work on cancer, HIV/AIDS, and genomics. He has founded more than a dozen biotechnology companies, and he serves on advisory boards for numerous international entities. He has authored more than 200 manuscripts in peer reviewed journals. Dr. Haseltine’s appointment follows the Board’s decision on November 14, 2019 to increase the size of the Board from 7 to 8 directors. Dr. Haseltine does not have any family relationship with any director, executive officer, or person nominated or chosen to become a director or executive officer of the company.